c-MET receptor as potential biomarker and target molecule for malignant testicular germ cell tumors

Type II testicular germ cell tumors (TGCTs) represent the most frequent malignancy in Caucasian males (20–40 years). Even if diagnosed with disseminated disease, >80% of patients are cured; however, a small percentage of cases progress and result in death. It is commonly accepted that these cance...

Descripción completa

Detalles Bibliográficos
Autores principales: Scheri, Katia Corano, Leonetti, Erica, Laino, Luigi, Gigantino, Vincenzo, Gesualdi, Luisa, Grammatico, Paola, Bizzari, Mariano, Franco, Renato, Oosterhuis, J. Wolter, Stoop, Hans, Looijenga, Leendert H.J., Ricci, Giulia, Catizone, Angela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6112764/
https://www.ncbi.nlm.nih.gov/pubmed/30159127
http://dx.doi.org/10.18632/oncotarget.25867

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6112764/
https://www.ncbi.nlm.nih.gov/pubmed/30159127
http://dx.doi.org/10.18632/oncotarget.25867

Ejemplares similares